John Rinn
Concepts (587)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 65 | 2025 | 177 | 16.710 |
Why?
| | RNA, Untranslated | 27 | 2021 | 124 | 5.820 |
Why?
| | Gene Expression Regulation | 49 | 2024 | 2608 | 4.300 |
Why?
| | Chromatin | 26 | 2023 | 561 | 3.610 |
Why?
| | RNA | 18 | 2026 | 940 | 2.780 |
Why?
| | Cell Nucleus | 14 | 2025 | 618 | 2.440 |
Why?
| | Transcription, Genetic | 29 | 2024 | 1496 | 2.260 |
Why?
| | Genome | 12 | 2022 | 306 | 2.170 |
Why?
| | Genome, Human | 18 | 2021 | 422 | 2.080 |
Why?
| | Epigenesis, Genetic | 18 | 2024 | 684 | 2.060 |
Why?
| | RNA-Binding Proteins | 16 | 2026 | 462 | 1.900 |
Why?
| | Enhancer Elements, Genetic | 10 | 2020 | 192 | 1.850 |
Why?
| | Promoter Regions, Genetic | 16 | 2021 | 1257 | 1.830 |
Why?
| | RNA, Messenger | 25 | 2021 | 2832 | 1.820 |
Why?
| | Tumor Suppressor Protein p53 | 8 | 2017 | 529 | 1.770 |
Why?
| | Repetitive Sequences, Nucleic Acid | 3 | 2021 | 117 | 1.580 |
Why?
| | Models, Genetic | 8 | 2018 | 536 | 1.560 |
Why?
| | Cell Differentiation | 26 | 2025 | 2050 | 1.420 |
Why?
| | Sequence Analysis, RNA | 14 | 2019 | 442 | 1.340 |
Why?
| | Ribonucleoproteins | 4 | 2025 | 103 | 1.300 |
Why?
| | Transcriptome | 12 | 2025 | 1045 | 1.290 |
Why?
| | Telomerase | 4 | 2024 | 248 | 1.280 |
Why?
| | Gene Deletion | 6 | 2021 | 389 | 1.270 |
Why?
| | X Chromosome Inactivation | 6 | 2024 | 27 | 1.260 |
Why?
| | Animals | 93 | 2025 | 38058 | 1.220 |
Why?
| | Introns | 6 | 2025 | 254 | 1.190 |
Why?
| | CCCTC-Binding Factor | 3 | 2024 | 12 | 1.180 |
Why?
| | Fibroblasts | 10 | 2018 | 1034 | 1.090 |
Why?
| | Base Sequence | 18 | 2020 | 2190 | 1.090 |
Why?
| | Mice | 61 | 2025 | 18339 | 1.090 |
Why?
| | Open Reading Frames | 8 | 2024 | 132 | 1.050 |
Why?
| | Genomics | 13 | 2022 | 834 | 1.040 |
Why?
| | Chromosomes | 3 | 2018 | 108 | 1.020 |
Why?
| | DNA, Complementary | 8 | 2020 | 276 | 1.020 |
Why?
| | Genetic Loci | 7 | 2020 | 261 | 1.000 |
Why?
| | Embryonic Stem Cells | 10 | 2015 | 130 | 0.980 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2018 | 35 | 0.980 |
Why?
| | RNA Splicing | 7 | 2025 | 284 | 0.940 |
Why?
| | RNA, Nuclear | 1 | 2025 | 5 | 0.930 |
Why?
| | Gene Expression Regulation, Developmental | 16 | 2023 | 905 | 0.900 |
Why?
| | Transcription Factors | 17 | 2020 | 1741 | 0.860 |
Why?
| | Molecular Sequence Annotation | 7 | 2020 | 105 | 0.860 |
Why?
| | Gene Expression Profiling | 29 | 2020 | 1782 | 0.840 |
Why?
| | Hematopoiesis | 3 | 2021 | 194 | 0.830 |
Why?
| | Mice, Knockout | 15 | 2025 | 3121 | 0.810 |
Why?
| | Humans | 123 | 2026 | 144759 | 0.810 |
Why?
| | Cell Line | 17 | 2024 | 2882 | 0.790 |
Why?
| | DNA Damage | 2 | 2017 | 430 | 0.790 |
Why?
| | Induced Pluripotent Stem Cells | 7 | 2021 | 276 | 0.760 |
Why?
| | Microscopy, Confocal | 3 | 2018 | 321 | 0.730 |
Why?
| | Fertility | 2 | 2020 | 168 | 0.730 |
Why?
| | Pluripotent Stem Cells | 6 | 2022 | 84 | 0.710 |
Why?
| | Regulatory Elements, Transcriptional | 4 | 2020 | 19 | 0.710 |
Why?
| | Binding Sites | 13 | 2024 | 1329 | 0.710 |
Why?
| | Polycomb Repressive Complex 2 | 5 | 2020 | 81 | 0.670 |
Why?
| | Computational Biology | 7 | 2021 | 680 | 0.670 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2026 | 549 | 0.660 |
Why?
| | Cellular Reprogramming | 4 | 2018 | 103 | 0.660 |
Why?
| | Cytoplasm | 3 | 2022 | 269 | 0.650 |
Why?
| | Hemorrhagic Fever, Ebola | 4 | 2023 | 81 | 0.650 |
Why?
| | Ebolavirus | 4 | 2023 | 89 | 0.640 |
Why?
| | Sequence Deletion | 3 | 2020 | 193 | 0.640 |
Why?
| | Evolution, Molecular | 4 | 2020 | 514 | 0.640 |
Why?
| | DNA | 7 | 2022 | 1463 | 0.630 |
Why?
| | Body Patterning | 4 | 2008 | 138 | 0.630 |
Why?
| | Nucleic Acid Conformation | 7 | 2024 | 726 | 0.620 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2020 | 2145 | 0.600 |
Why?
| | K562 Cells | 5 | 2021 | 93 | 0.600 |
Why?
| | Embryonic Development | 6 | 2019 | 125 | 0.590 |
Why?
| | Oligonucleotide Array Sequence Analysis | 17 | 2016 | 758 | 0.590 |
Why?
| | Repressor Proteins | 7 | 2018 | 437 | 0.590 |
Why?
| | Alleles | 6 | 2024 | 879 | 0.580 |
Why?
| | DNA-Binding Proteins | 7 | 2021 | 1499 | 0.580 |
Why?
| | In Situ Hybridization, Fluorescence | 7 | 2021 | 322 | 0.580 |
Why?
| | Organ Specificity | 6 | 2019 | 312 | 0.560 |
Why?
| | Molecular Sequence Data | 10 | 2015 | 2930 | 0.550 |
Why?
| | Chromosomes, Human | 1 | 2018 | 41 | 0.550 |
Why?
| | Time-Lapse Imaging | 1 | 2018 | 22 | 0.550 |
Why?
| | Sequence Analysis, DNA | 3 | 2016 | 824 | 0.540 |
Why?
| | Chromosomes, Human, X | 1 | 2018 | 76 | 0.540 |
Why?
| | Endogenous Retroviruses | 2 | 2022 | 38 | 0.540 |
Why?
| | Chromosome Aberrations | 1 | 2018 | 162 | 0.530 |
Why?
| | DNA Methylation | 8 | 2022 | 681 | 0.520 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 458 | 0.510 |
Why?
| | Gene Expression Regulation, Neoplastic | 6 | 2019 | 1455 | 0.490 |
Why?
| | Phenotype | 8 | 2024 | 3162 | 0.480 |
Why?
| | Genomic Imprinting | 3 | 2024 | 26 | 0.470 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 112 | 0.470 |
Why?
| | DNA, Satellite | 1 | 2015 | 18 | 0.470 |
Why?
| | Homeodomain Proteins | 6 | 2013 | 523 | 0.460 |
Why?
| | Gene Regulatory Networks | 7 | 2018 | 318 | 0.460 |
Why?
| | DNA, Intergenic | 4 | 2011 | 29 | 0.460 |
Why?
| | Genes, Homeobox | 5 | 2013 | 50 | 0.450 |
Why?
| | Plasmodium falciparum | 2 | 2015 | 39 | 0.450 |
Why?
| | Centromere | 1 | 2015 | 59 | 0.450 |
Why?
| | Protein Binding | 13 | 2026 | 2273 | 0.430 |
Why?
| | Neoplasms | 5 | 2019 | 2875 | 0.430 |
Why?
| | DNA Transposable Elements | 1 | 2014 | 122 | 0.410 |
Why?
| | Nuclear Proteins | 3 | 2016 | 748 | 0.400 |
Why?
| | X Chromosome | 3 | 2024 | 67 | 0.390 |
Why?
| | Myoblasts | 3 | 2022 | 84 | 0.390 |
Why?
| | HeLa Cells | 8 | 2021 | 650 | 0.390 |
Why?
| | Immunoprecipitation | 3 | 2026 | 151 | 0.390 |
Why?
| | Systems Biology | 3 | 2011 | 72 | 0.390 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 148 | 0.390 |
Why?
| | Proteins | 7 | 2024 | 1021 | 0.380 |
Why?
| | RNA Interference | 7 | 2021 | 476 | 0.380 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2014 | 167 | 0.370 |
Why?
| | Adipogenesis | 1 | 2013 | 57 | 0.370 |
Why?
| | Retroelements | 1 | 2012 | 51 | 0.370 |
Why?
| | HEK293 Cells | 7 | 2021 | 744 | 0.370 |
Why?
| | Cells, Cultured | 16 | 2021 | 4154 | 0.370 |
Why?
| | Homeostasis | 4 | 2021 | 640 | 0.360 |
Why?
| | Skin | 2 | 2008 | 755 | 0.360 |
Why?
| | Brain | 2 | 2015 | 2933 | 0.360 |
Why?
| | Epidermis | 2 | 2012 | 157 | 0.340 |
Why?
| | Human Embryonic Stem Cells | 2 | 2021 | 26 | 0.340 |
Why?
| | High-Throughput Screening Assays | 3 | 2026 | 175 | 0.340 |
Why?
| | RNA Stability | 5 | 2021 | 119 | 0.340 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 2023 | 96 | 0.330 |
Why?
| | Conserved Sequence | 6 | 2020 | 245 | 0.320 |
Why?
| | Down-Regulation | 3 | 2016 | 627 | 0.320 |
Why?
| | Histones | 11 | 2021 | 669 | 0.320 |
Why?
| | Muscle Development | 3 | 2022 | 116 | 0.310 |
Why?
| | Chromosomes, Human, Pair 22 | 4 | 2004 | 46 | 0.310 |
Why?
| | Mouse Embryonic Stem Cells | 3 | 2020 | 38 | 0.300 |
Why?
| | Gene Library | 4 | 2018 | 126 | 0.300 |
Why?
| | Telomere | 2 | 2019 | 288 | 0.300 |
Why?
| | MicroRNAs | 8 | 2021 | 701 | 0.290 |
Why?
| | Sex Characteristics | 2 | 2005 | 790 | 0.290 |
Why?
| | Single-Cell Analysis | 5 | 2020 | 358 | 0.290 |
Why?
| | Gene Editing | 2 | 2021 | 93 | 0.290 |
Why?
| | Mammals | 5 | 2021 | 293 | 0.290 |
Why?
| | CRISPR-Cas Systems | 3 | 2021 | 170 | 0.280 |
Why?
| | Nucleotide Motifs | 3 | 2017 | 36 | 0.280 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2194 | 0.270 |
Why?
| | Cell Lineage | 5 | 2021 | 376 | 0.260 |
Why?
| | Immunity, Innate | 3 | 2019 | 846 | 0.260 |
Why?
| | Lymphopoiesis | 2 | 2021 | 27 | 0.260 |
Why?
| | Chromatin Assembly and Disassembly | 5 | 2017 | 109 | 0.260 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 3 | 2022 | 37 | 0.260 |
Why?
| | Wnt Proteins | 1 | 2008 | 133 | 0.250 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 3 | 2022 | 16 | 0.240 |
Why?
| | Reproducibility of Results | 6 | 2021 | 3409 | 0.240 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 845 | 0.240 |
Why?
| | HCT116 Cells | 3 | 2021 | 78 | 0.230 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 310 | 0.230 |
Why?
| | Exons | 4 | 2016 | 358 | 0.220 |
Why?
| | Databases, Genetic | 4 | 2020 | 248 | 0.220 |
Why?
| | Genes, X-Linked | 1 | 2024 | 21 | 0.220 |
Why?
| | Myosin Heavy Chains | 2 | 2021 | 185 | 0.220 |
Why?
| | Proto-Oncogene Proteins | 1 | 2008 | 623 | 0.210 |
Why?
| | Genitalia | 1 | 2004 | 34 | 0.210 |
Why?
| | Motor Neurons | 3 | 2015 | 234 | 0.210 |
Why?
| | Gene Knockdown Techniques | 4 | 2013 | 336 | 0.210 |
Why?
| | Male | 21 | 2024 | 72315 | 0.210 |
Why?
| | Signal Transduction | 11 | 2021 | 5226 | 0.210 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2023 | 16 | 0.200 |
Why?
| | Immunologic Memory | 1 | 2025 | 366 | 0.200 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2019 | 881 | 0.190 |
Why?
| | Cluster Analysis | 5 | 2015 | 521 | 0.190 |
Why?
| | Alternative Splicing | 2 | 2018 | 247 | 0.190 |
Why?
| | Databases, Nucleic Acid | 2 | 2021 | 39 | 0.190 |
Why?
| | NF-kappa B | 4 | 2020 | 661 | 0.190 |
Why?
| | Zebrafish | 4 | 2013 | 528 | 0.190 |
Why?
| | Plasmids | 1 | 2023 | 379 | 0.190 |
Why?
| | Pharmaceutical Preparations | 1 | 2004 | 170 | 0.180 |
Why?
| | Female | 23 | 2024 | 78271 | 0.180 |
Why?
| | Mitosis | 2 | 2021 | 200 | 0.180 |
Why?
| | RNA Transport | 3 | 2016 | 27 | 0.180 |
Why?
| | Ribonucleases | 2 | 2019 | 49 | 0.180 |
Why?
| | Gene Targeting | 1 | 2021 | 82 | 0.170 |
Why?
| | Genetic Techniques | 2 | 2013 | 67 | 0.170 |
Why?
| | Mice, Inbred Strains | 2 | 2019 | 397 | 0.170 |
Why?
| | Ectoderm | 1 | 2021 | 53 | 0.170 |
Why?
| | Genetic Association Studies | 3 | 2014 | 372 | 0.170 |
Why?
| | Cell Compartmentation | 1 | 2021 | 54 | 0.170 |
Why?
| | Mice, Inbred C57BL | 11 | 2025 | 5992 | 0.170 |
Why?
| | Research Report | 1 | 2021 | 87 | 0.170 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 7 | 2016 | 983 | 0.170 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2022 | 214 | 0.170 |
Why?
| | Cardiac Myosins | 1 | 2021 | 37 | 0.170 |
Why?
| | Stem Cells | 3 | 2022 | 626 | 0.170 |
Why?
| | Receptor, Insulin | 1 | 2021 | 94 | 0.170 |
Why?
| | Ikaros Transcription Factor | 1 | 2021 | 23 | 0.170 |
Why?
| | Epigenomics | 2 | 2011 | 114 | 0.160 |
Why?
| | Lipopolysaccharides | 3 | 2019 | 863 | 0.160 |
Why?
| | Polycomb-Group Proteins | 3 | 2010 | 36 | 0.160 |
Why?
| | Telomere Homeostasis | 1 | 2020 | 33 | 0.160 |
Why?
| | Spermatogenesis | 1 | 2020 | 91 | 0.160 |
Why?
| | Eukaryotic Cells | 1 | 2020 | 40 | 0.160 |
Why?
| | Placenta | 3 | 2021 | 780 | 0.160 |
Why?
| | Congresses as Topic | 1 | 2021 | 221 | 0.160 |
Why?
| | RNA Precursors | 1 | 2021 | 156 | 0.160 |
Why?
| | Species Specificity | 1 | 2021 | 574 | 0.150 |
Why?
| | Protein Domains | 2 | 2020 | 313 | 0.150 |
Why?
| | Preimplantation Diagnosis | 1 | 2019 | 6 | 0.150 |
Why?
| | Dactinomycin | 1 | 2019 | 27 | 0.150 |
Why?
| | RNA Processing, Post-Transcriptional | 3 | 2018 | 92 | 0.150 |
Why?
| | Genome-Wide Association Study | 4 | 2020 | 1406 | 0.150 |
Why?
| | Embryo Implantation | 1 | 2019 | 30 | 0.150 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 67 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 917 | 0.150 |
Why?
| | Apoptosis | 4 | 2018 | 2430 | 0.150 |
Why?
| | Drug Tolerance | 1 | 2019 | 100 | 0.150 |
Why?
| | Organelles | 2 | 2017 | 57 | 0.150 |
Why?
| | Structure-Activity Relationship | 1 | 2020 | 570 | 0.140 |
Why?
| | RNA, Fungal | 2 | 2010 | 73 | 0.140 |
Why?
| | Fertilization in Vitro | 1 | 2019 | 92 | 0.140 |
Why?
| | Pattern Recognition, Automated | 1 | 2019 | 74 | 0.140 |
Why?
| | Protein Conformation | 2 | 2021 | 946 | 0.140 |
Why?
| | Transgenes | 3 | 2020 | 189 | 0.140 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2018 | 21 | 0.140 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2018 | 28 | 0.140 |
Why?
| | Binding, Competitive | 2 | 2020 | 193 | 0.140 |
Why?
| | Cell Proliferation | 7 | 2020 | 2496 | 0.140 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2018 | 55 | 0.140 |
Why?
| | Time Factors | 4 | 2024 | 7173 | 0.140 |
Why?
| | Mutation | 6 | 2024 | 4089 | 0.140 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 269 | 0.140 |
Why?
| | Cell Line, Tumor | 4 | 2021 | 3540 | 0.140 |
Why?
| | Adipocytes | 1 | 2020 | 223 | 0.140 |
Why?
| | HMGA2 Protein | 1 | 2018 | 10 | 0.140 |
Why?
| | Molecular Imaging | 1 | 2018 | 55 | 0.140 |
Why?
| | Cell Nucleolus | 1 | 2018 | 20 | 0.140 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2017 | 339 | 0.140 |
Why?
| | Cyclooxygenase 2 | 1 | 2018 | 165 | 0.140 |
Why?
| | Lymphocytes | 2 | 2017 | 382 | 0.130 |
Why?
| | Immunity | 1 | 2018 | 139 | 0.130 |
Why?
| | Macaca mulatta | 3 | 2023 | 191 | 0.130 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2018 | 142 | 0.130 |
Why?
| | Translocation, Genetic | 1 | 2018 | 115 | 0.130 |
Why?
| | Consensus Sequence | 2 | 2016 | 74 | 0.130 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 262 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2021 | 266 | 0.130 |
Why?
| | Pyramidal Tracts | 2 | 2014 | 30 | 0.130 |
Why?
| | Retinal Pigment Epithelium | 1 | 2018 | 80 | 0.130 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 371 | 0.130 |
Why?
| | Staining and Labeling | 1 | 2017 | 151 | 0.130 |
Why?
| | Splicing Factor U2AF | 1 | 2016 | 18 | 0.130 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2016 | 37 | 0.120 |
Why?
| | Histone Deacetylases | 1 | 2018 | 210 | 0.120 |
Why?
| | Genotype | 1 | 2021 | 1833 | 0.120 |
Why?
| | Histocompatibility, Maternal-Fetal | 1 | 2016 | 2 | 0.120 |
Why?
| | HLA-G Antigens | 1 | 2016 | 2 | 0.120 |
Why?
| | Genetic Testing | 1 | 2019 | 478 | 0.120 |
Why?
| | Support Vector Machine | 1 | 2016 | 36 | 0.120 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 108 | 0.120 |
Why?
| | GTP-Binding Protein gamma Subunits | 1 | 2016 | 10 | 0.120 |
Why?
| | Kidney | 1 | 2004 | 1495 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2018 | 780 | 0.120 |
Why?
| | Chromatin Assembly Factor-1 | 1 | 2015 | 12 | 0.120 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2016 | 121 | 0.120 |
Why?
| | Myocardium | 1 | 2021 | 939 | 0.120 |
Why?
| | Methylation | 5 | 2020 | 242 | 0.120 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2015 | 18 | 0.120 |
Why?
| | PTEN Phosphohydrolase | 2 | 2016 | 164 | 0.120 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 246 | 0.110 |
Why?
| | rho GTP-Binding Proteins | 1 | 2016 | 56 | 0.110 |
Why?
| | Immunohistochemistry | 3 | 2015 | 1716 | 0.110 |
Why?
| | Chondrocytes | 1 | 2018 | 232 | 0.110 |
Why?
| | Gene Expression | 4 | 2015 | 1490 | 0.110 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2015 | 25 | 0.110 |
Why?
| | Liver | 1 | 2004 | 1887 | 0.110 |
Why?
| | Nervous System | 1 | 2015 | 70 | 0.110 |
Why?
| | Pseudogenes | 2 | 2014 | 20 | 0.110 |
Why?
| | Genes | 1 | 2015 | 226 | 0.110 |
Why?
| | beta-Galactosidase | 1 | 2015 | 77 | 0.110 |
Why?
| | RNA, Protozoan | 1 | 2015 | 60 | 0.110 |
Why?
| | Myeloid Cells | 1 | 2016 | 148 | 0.110 |
Why?
| | Doxorubicin | 1 | 2017 | 397 | 0.110 |
Why?
| | Maternal-Fetal Exchange | 1 | 2016 | 169 | 0.110 |
Why?
| | STAT3 Transcription Factor | 1 | 2016 | 207 | 0.110 |
Why?
| | Gene Silencing | 2 | 2013 | 205 | 0.110 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2018 | 433 | 0.110 |
Why?
| | RNA, Catalytic | 1 | 2015 | 189 | 0.110 |
Why?
| | Erythrocytes | 1 | 2020 | 757 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 420 | 0.110 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 120 | 0.110 |
Why?
| | Molecular Biology | 1 | 2015 | 59 | 0.110 |
Why?
| | Lysine | 3 | 2020 | 302 | 0.110 |
Why?
| | Kinetics | 1 | 2018 | 1627 | 0.110 |
Why?
| | Pyramidal Cells | 1 | 2014 | 79 | 0.100 |
Why?
| | Neocortex | 1 | 2014 | 49 | 0.100 |
Why?
| | Protein Footprinting | 1 | 2014 | 11 | 0.100 |
Why?
| | Neurotransmitter Agents | 1 | 2014 | 82 | 0.100 |
Why?
| | Keratinocytes | 2 | 2012 | 248 | 0.100 |
Why?
| | Neurons | 2 | 2021 | 1640 | 0.100 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2018 | 682 | 0.100 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2013 | 38 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 573 | 0.100 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2011 | 157 | 0.100 |
Why?
| | Trophoblasts | 1 | 2016 | 216 | 0.100 |
Why?
| | Pregnancy | 4 | 2023 | 7190 | 0.100 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 1129 | 0.100 |
Why?
| | Nerve Tissue Proteins | 2 | 2014 | 592 | 0.100 |
Why?
| | Information Theory | 1 | 2013 | 5 | 0.100 |
Why?
| | Neuronal Plasticity | 1 | 2015 | 309 | 0.090 |
Why?
| | Fetus | 1 | 2017 | 803 | 0.090 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 67 | 0.090 |
Why?
| | Protein Array Analysis | 1 | 2012 | 56 | 0.090 |
Why?
| | Inhibitor of Differentiation Protein 2 | 2 | 2025 | 5 | 0.090 |
Why?
| | Nervous System Diseases | 1 | 2015 | 284 | 0.090 |
Why?
| | Ubiquitination | 1 | 2013 | 118 | 0.090 |
Why?
| | Mice, Transgenic | 5 | 2020 | 2182 | 0.090 |
Why?
| | Adipocytes, Brown | 1 | 2012 | 8 | 0.090 |
Why?
| | Adipocytes, White | 1 | 2012 | 18 | 0.090 |
Why?
| | Genes, Overlapping | 1 | 2011 | 2 | 0.090 |
Why?
| | Ribosomes | 1 | 2013 | 191 | 0.090 |
Why?
| | Models, Biological | 1 | 2019 | 1821 | 0.090 |
Why?
| | Genome, Protozoan | 1 | 2011 | 2 | 0.090 |
Why?
| | Genes, Protozoan | 1 | 2011 | 13 | 0.090 |
Why?
| | Biological Evolution | 1 | 2015 | 488 | 0.090 |
Why?
| | Registries | 1 | 2020 | 2385 | 0.090 |
Why?
| | Disease | 1 | 2012 | 98 | 0.080 |
Why?
| | Models, Statistical | 2 | 2024 | 681 | 0.080 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 5 | 0.080 |
Why?
| | Artifacts | 1 | 2011 | 139 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2011 | 366 | 0.080 |
Why?
| | Mitochondria | 2 | 2020 | 984 | 0.080 |
Why?
| | Colonic Neoplasms | 1 | 2013 | 259 | 0.080 |
Why?
| | Argonaute Proteins | 3 | 2016 | 31 | 0.080 |
Why?
| | Sexual Maturation | 1 | 2010 | 51 | 0.080 |
Why?
| | Octamer Transcription Factor-3 | 2 | 2021 | 19 | 0.080 |
Why?
| | Body Size | 1 | 2010 | 95 | 0.080 |
Why?
| | Insulin | 2 | 2018 | 2507 | 0.070 |
Why?
| | Thymus Gland | 2 | 2008 | 311 | 0.070 |
Why?
| | Adenocarcinoma | 1 | 2016 | 928 | 0.070 |
Why?
| | Prostatic Neoplasms | 1 | 2016 | 974 | 0.070 |
Why?
| | Chromosome Mapping | 3 | 2004 | 510 | 0.070 |
Why?
| | Saccharomyces cerevisiae | 2 | 2010 | 579 | 0.070 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2008 | 18 | 0.070 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2009 | 72 | 0.070 |
Why?
| | Myosin Type V | 1 | 2008 | 9 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2010 | 236 | 0.070 |
Why?
| | Wnt-5a Protein | 1 | 2008 | 24 | 0.070 |
Why?
| | Chromosome Disorders | 1 | 2008 | 45 | 0.070 |
Why?
| | Zebrafish Proteins | 2 | 2010 | 311 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2009 | 320 | 0.070 |
Why?
| | Proteome | 1 | 2012 | 518 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2020 | 2155 | 0.070 |
Why?
| | Cell Survival | 3 | 2016 | 1098 | 0.060 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 688 | 0.060 |
Why?
| | Keratins | 1 | 2008 | 172 | 0.060 |
Why?
| | Genes, Reporter | 2 | 2020 | 275 | 0.060 |
Why?
| | Autoantigens | 2 | 2008 | 429 | 0.060 |
Why?
| | Viruses | 1 | 2009 | 165 | 0.060 |
Why?
| | Zinc Fingers | 1 | 2007 | 53 | 0.060 |
Why?
| | Retinol-Binding Proteins | 1 | 2006 | 17 | 0.060 |
Why?
| | Epithelium | 1 | 2008 | 314 | 0.060 |
Why?
| | Peptides | 1 | 2012 | 995 | 0.060 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 173 | 0.060 |
Why?
| | Bacteria | 2 | 2013 | 889 | 0.060 |
Why?
| | ras Proteins | 1 | 2007 | 150 | 0.060 |
Why?
| | Protozoan Proteins | 1 | 2007 | 93 | 0.060 |
Why?
| | Software | 1 | 2012 | 690 | 0.060 |
Why?
| | Wound Healing | 1 | 2009 | 351 | 0.060 |
Why?
| | Eye Proteins | 1 | 2006 | 90 | 0.060 |
Why?
| | Algorithms | 1 | 2014 | 1837 | 0.060 |
Why?
| | Breast Neoplasms | 2 | 2016 | 2452 | 0.060 |
Why?
| | Dendritic Cells | 1 | 2009 | 499 | 0.060 |
Why?
| | Up-Regulation | 2 | 2020 | 851 | 0.060 |
Why?
| | Monocytes | 2 | 2020 | 538 | 0.060 |
Why?
| | Lectins, C-Type | 1 | 2025 | 62 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2006 | 327 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2021 | 635 | 0.060 |
Why?
| | T-Box Domain Proteins | 1 | 2025 | 106 | 0.060 |
Why?
| | Quantitative Trait Loci | 2 | 2020 | 374 | 0.060 |
Why?
| | Neoplastic Stem Cells | 1 | 2009 | 412 | 0.050 |
Why?
| | Transcortin | 1 | 2004 | 14 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2025 | 206 | 0.050 |
Why?
| | Levivirus | 1 | 2024 | 18 | 0.050 |
Why?
| | Serpins | 1 | 2004 | 28 | 0.050 |
Why?
| | Biophysical Phenomena | 1 | 2024 | 68 | 0.050 |
Why?
| | Metabolic Clearance Rate | 1 | 2004 | 114 | 0.050 |
Why?
| | RNA Polymerase II | 2 | 2023 | 351 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2008 | 419 | 0.050 |
Why?
| | Testis | 1 | 2004 | 163 | 0.050 |
Why?
| | Hypothalamus | 1 | 2004 | 153 | 0.050 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 145 | 0.050 |
Why?
| | Virus Internalization | 1 | 2023 | 65 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2016 | 139 | 0.050 |
Why?
| | Endoderm | 1 | 2023 | 21 | 0.050 |
Why?
| | SOXF Transcription Factors | 1 | 2023 | 16 | 0.050 |
Why?
| | Selection, Genetic | 1 | 2005 | 256 | 0.050 |
Why?
| | Poly A | 1 | 2003 | 50 | 0.050 |
Why?
| | Ovary | 1 | 2004 | 228 | 0.050 |
Why?
| | Autoimmune Diseases | 1 | 2006 | 463 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2022 | 17 | 0.050 |
Why?
| | Cytoskeletal Proteins | 2 | 2012 | 156 | 0.050 |
Why?
| | Neoplasm Invasiveness | 2 | 2016 | 508 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 377 | 0.040 |
Why?
| | RNA, Small Untranslated | 1 | 2021 | 14 | 0.040 |
Why?
| | Histone Demethylases | 2 | 2015 | 38 | 0.040 |
Why?
| | Macrophages | 2 | 2020 | 1511 | 0.040 |
Why?
| | Primates | 1 | 2022 | 132 | 0.040 |
Why?
| | Smad1 Protein | 1 | 2020 | 17 | 0.040 |
Why?
| | Myelopoiesis | 1 | 2020 | 10 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 219 | 0.040 |
Why?
| | Oligonucleotide Probes | 2 | 2015 | 50 | 0.040 |
Why?
| | Cochlear Nucleus | 1 | 2000 | 5 | 0.040 |
Why?
| | Gene Ontology | 1 | 2020 | 53 | 0.040 |
Why?
| | Bystander Effect | 1 | 2020 | 19 | 0.040 |
Why?
| | Disease Models, Animal | 4 | 2017 | 4557 | 0.040 |
Why?
| | DNA Replication Timing | 1 | 2020 | 4 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 202 | 0.040 |
Why?
| | DNA Footprinting | 1 | 2020 | 33 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 138 | 0.040 |
Why?
| | Transposases | 1 | 2020 | 19 | 0.040 |
Why?
| | Deoxyribonuclease I | 1 | 2020 | 41 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1098 | 0.040 |
Why?
| | CpG Islands | 2 | 2015 | 165 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2000 | 55 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 175 | 0.040 |
Why?
| | RNA, Viral | 1 | 2024 | 688 | 0.040 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2020 | 94 | 0.040 |
Why?
| | Static Electricity | 1 | 2020 | 113 | 0.040 |
Why?
| | Cell Respiration | 1 | 2020 | 107 | 0.040 |
Why?
| | Genetic Variation | 1 | 2005 | 983 | 0.040 |
Why?
| | Karyotype | 1 | 2019 | 19 | 0.040 |
Why?
| | Potassium Channels | 1 | 2000 | 145 | 0.040 |
Why?
| | Karyotyping | 1 | 2019 | 106 | 0.040 |
Why?
| | Blastocyst | 1 | 2019 | 47 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 188 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 259 | 0.040 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2020 | 364 | 0.040 |
Why?
| | Cell Movement | 2 | 2016 | 965 | 0.040 |
Why?
| | Interphase | 1 | 2018 | 38 | 0.040 |
Why?
| | HL-60 Cells | 1 | 2018 | 29 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2014 | 1173 | 0.030 |
Why?
| | Regenerative Medicine | 1 | 2018 | 50 | 0.030 |
Why?
| | Genes, Switch | 1 | 2018 | 6 | 0.030 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2018 | 12 | 0.030 |
Why?
| | Cytarabine | 1 | 2018 | 66 | 0.030 |
Why?
| | GATA4 Transcription Factor | 1 | 2018 | 19 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 380 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 2018 | 124 | 0.030 |
Why?
| | Biotinylation | 1 | 2017 | 37 | 0.030 |
Why?
| | Hep G2 Cells | 1 | 2018 | 74 | 0.030 |
Why?
| | A549 Cells | 1 | 2018 | 75 | 0.030 |
Why?
| | Internet | 1 | 2003 | 699 | 0.030 |
Why?
| | Inflammation | 1 | 2009 | 2878 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2018 | 66 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2017 | 52 | 0.030 |
Why?
| | Antigens, CD | 1 | 2020 | 555 | 0.030 |
Why?
| | Lymphocyte Subsets | 1 | 2017 | 83 | 0.030 |
Why?
| | Oncogene Protein pp60(v-src) | 1 | 2016 | 4 | 0.030 |
Why?
| | Pharmacogenetics | 1 | 2018 | 172 | 0.030 |
Why?
| | Mice, Nude | 2 | 2010 | 682 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2016 | 40 | 0.030 |
Why?
| | Macaca | 1 | 2016 | 65 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2016 | 135 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 508 | 0.030 |
Why?
| | Phosphorylation | 1 | 2021 | 1732 | 0.030 |
Why?
| | Mammary Glands, Human | 1 | 2016 | 67 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2020 | 527 | 0.030 |
Why?
| | Immunogenetic Phenomena | 1 | 2016 | 7 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2021 | 556 | 0.030 |
Why?
| | Cell Fractionation | 1 | 2016 | 52 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1087 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2020 | 737 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1075 | 0.030 |
Why?
| | RNA Polymerase III | 1 | 2016 | 34 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2010 | 1253 | 0.030 |
Why?
| | Mice, Inbred NOD | 2 | 2008 | 610 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2015 | 133 | 0.030 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2014 | 6 | 0.030 |
Why?
| | Heterochromatin | 1 | 2015 | 67 | 0.030 |
Why?
| | Transcriptional Activation | 2 | 2010 | 383 | 0.030 |
Why?
| | Lipids | 1 | 2020 | 710 | 0.030 |
Why?
| | Blood | 1 | 2015 | 109 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1618 | 0.030 |
Why?
| | DNA Repair | 1 | 2017 | 256 | 0.030 |
Why?
| | Genes, Suppressor | 1 | 2014 | 4 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 116 | 0.030 |
Why?
| | Corpus Callosum | 1 | 2014 | 72 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 940 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 246 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2016 | 402 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2015 | 232 | 0.030 |
Why?
| | Killer Cells, Natural | 1 | 2017 | 467 | 0.030 |
Why?
| | Precipitin Tests | 2 | 2004 | 93 | 0.030 |
Why?
| | Membrane Transport Proteins | 1 | 2015 | 154 | 0.030 |
Why?
| | Autoimmunity | 1 | 2020 | 926 | 0.030 |
Why?
| | RNA Editing | 1 | 2014 | 26 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1195 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2020 | 935 | 0.030 |
Why?
| | Eosinophils | 1 | 2016 | 316 | 0.030 |
Why?
| | Nucleosomes | 1 | 2015 | 165 | 0.030 |
Why?
| | Computer Simulation | 1 | 2018 | 1025 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 383 | 0.030 |
Why?
| | RNA Isoforms | 1 | 2013 | 2 | 0.020 |
Why?
| | Blotting, Western | 1 | 2016 | 1187 | 0.020 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2017 | 291 | 0.020 |
Why?
| | Virus Replication | 1 | 2016 | 529 | 0.020 |
Why?
| | HapMap Project | 1 | 2013 | 4 | 0.020 |
Why?
| | Ataxins | 1 | 2013 | 5 | 0.020 |
Why?
| | Ataxin-1 | 1 | 2013 | 5 | 0.020 |
Why?
| | RNA Cap-Binding Proteins | 1 | 2013 | 3 | 0.020 |
Why?
| | ELAV Proteins | 1 | 2013 | 14 | 0.020 |
Why?
| | Toll-Like Receptor 5 | 1 | 2013 | 18 | 0.020 |
Why?
| | Flagellin | 1 | 2013 | 19 | 0.020 |
Why?
| | Neurogenesis | 1 | 2014 | 156 | 0.020 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 89 | 0.020 |
Why?
| | Cell Cycle | 1 | 2016 | 596 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2013 | 388 | 0.020 |
Why?
| | Cytokines | 1 | 2020 | 2061 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 148 | 0.020 |
Why?
| | Multigene Family | 1 | 2013 | 204 | 0.020 |
Why?
| | Lung | 2 | 2018 | 4109 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 321 | 0.020 |
Why?
| | Codon | 1 | 2012 | 94 | 0.020 |
Why?
| | Acetylation | 1 | 2013 | 252 | 0.020 |
Why?
| | Tretinoin | 1 | 2013 | 124 | 0.020 |
Why?
| | History, 21st Century | 1 | 2013 | 219 | 0.020 |
Why?
| | RNA Folding | 1 | 2012 | 35 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2363 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 33 | 0.020 |
Why?
| | Genetic Research | 1 | 2011 | 17 | 0.020 |
Why?
| | History, 20th Century | 1 | 2013 | 325 | 0.020 |
Why?
| | 3T3 Cells | 1 | 2012 | 156 | 0.020 |
Why?
| | Adipose Tissue, White | 1 | 2012 | 43 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2011 | 43 | 0.020 |
Why?
| | Data Mining | 1 | 2012 | 117 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 253 | 0.020 |
Why?
| | Adipose Tissue, Brown | 1 | 2012 | 59 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2013 | 292 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2012 | 193 | 0.020 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2012 | 59 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 192 | 0.020 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 209 | 0.020 |
Why?
| | Skin Diseases | 1 | 2012 | 149 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 380 | 0.020 |
Why?
| | PPAR gamma | 1 | 2012 | 176 | 0.020 |
Why?
| | Neutrophils | 1 | 2016 | 1134 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2013 | 226 | 0.020 |
Why?
| | Gene Dosage | 1 | 2011 | 148 | 0.020 |
Why?
| | Zygote | 1 | 2010 | 14 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2013 | 479 | 0.020 |
Why?
| | Bias | 1 | 2011 | 202 | 0.020 |
Why?
| | Lipopeptides | 1 | 2009 | 16 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2010 | 251 | 0.020 |
Why?
| | Poly I-C | 1 | 2009 | 57 | 0.020 |
Why?
| | Career Choice | 1 | 2011 | 237 | 0.020 |
Why?
| | Feedback, Physiological | 1 | 2009 | 83 | 0.020 |
Why?
| | Oncogene Proteins v-myb | 1 | 2009 | 1 | 0.020 |
Why?
| | HMGB3 Protein | 1 | 2009 | 1 | 0.020 |
Why?
| | Mice, SCID | 1 | 2010 | 369 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4271 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 299 | 0.020 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2009 | 56 | 0.020 |
Why?
| | Random Allocation | 1 | 2009 | 363 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2009 | 119 | 0.020 |
Why?
| | Models, Animal | 1 | 2010 | 392 | 0.020 |
Why?
| | Lacrimal Apparatus | 1 | 2008 | 9 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2009 | 194 | 0.020 |
Why?
| | Salivary Glands | 1 | 2008 | 36 | 0.020 |
Why?
| | Polyribosomes | 1 | 2008 | 22 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2009 | 132 | 0.020 |
Why?
| | Secretory Vesicles | 1 | 2008 | 24 | 0.020 |
Why?
| | Vacuoles | 1 | 2008 | 38 | 0.020 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 17 | 0.020 |
Why?
| | Leukocytes | 1 | 2009 | 295 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2008 | 224 | 0.020 |
Why?
| | Eye | 1 | 2008 | 109 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2008 | 162 | 0.020 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2007 | 64 | 0.020 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2009 | 210 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2007 | 173 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 512 | 0.020 |
Why?
| | Actins | 1 | 2008 | 425 | 0.010 |
Why?
| | Uveitis | 1 | 2006 | 148 | 0.010 |
Why?
| | Survival Rate | 1 | 2010 | 2089 | 0.010 |
Why?
| | Glucose | 1 | 2010 | 1047 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 2004 | 187 | 0.010 |
Why?
| | Colforsin | 1 | 2004 | 48 | 0.010 |
Why?
| | Transcription Factor RelA | 1 | 2003 | 85 | 0.010 |
Why?
| | Disease Progression | 1 | 2010 | 2847 | 0.010 |
Why?
| | Quality Improvement | 1 | 2011 | 1289 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 4282 | 0.010 |
Why?
| | Shal Potassium Channels | 1 | 2000 | 5 | 0.010 |
Why?
| | Mice, Inbred CBA | 1 | 2000 | 57 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1370 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 319 | 0.010 |
Why?
| | Blood Glucose | 1 | 2010 | 2327 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1217 | 0.010 |
Why?
| | Middle Aged | 1 | 2010 | 35875 | 0.000 |
Why?
|
|
Rinn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|